Ramipril Krka 2,5 mg Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ramipril krka 2,5 mg

krka, d.d., novo mesto, slovinsko - ramipril - 58 - hypotensiva

GalliaPharm Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

galliapharm

eckert & ziegler radiopharma gmbh, nemecko - iné diagnostické rádiofarmaká - 88 - radiopharmaca

PREMED 300 mg Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

premed 300 mg

cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva

PREMED 150 mg Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

premed 150 mg

cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva

PREMED 75 mg Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

premed 75 mg

cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva

Verzenios Europos Sąjunga - slovakų - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.